(Stroke. 1997;28:2039-2044.)
© 1997 American Heart Association, Inc.
Articles |
Rapid Induction of Vascular Endothelial Growth Factor Gene Expression After Transient Middle Cerebral Artery Occlusion in Rats
From the Department of Neurology, Tohoku University School of Medicine (T.H., K.A., H.S., Y.I.), and Department of Pharmaceutical Services, Tohoku Kouseinenkin Hospital (H.S.), Sendai, Japan.
Correspondence to K. Abe, MD, PhD, Department of Neurology, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku 980-77, Sendai, Japan. E-mail hayashi{at}neurol.med.tohoku.ac.jp
Background and Purpose Vascular endothelial growth factor (VEGF) is a mitogen for endothelial cells and also has the potential to increase vascular permeability. Therefore, it may contribute to the recovery of brain cells from ischemic insult through potentiating neovascularization or may exacerbate brain damage by forming brain edema. However, the exact role of this protein in cerebral ischemia is not fully understood. We investigated temporal, spatial, and cellular profiles of the induction of VEGF gene expression after transient focal cerebral ischemia at both mRNA and protein levels.
Methods We used a transient middle cerebral artery (MCA) occlusion model. Northern blot analysis was performed to assess the chronological pattern of induction and the impact of length of ischemia on mRNA expression. Western blot analysis was performed to ensure the selective detection of immunoreactive VEGF with an antibody. Temporal, spatial, and cellular changes of immunohistochemical VEGF expression were compared with different periods of reperfusion from 1 hour to 7 days after transient MCA occlusion.
Results (1) Northern blot analysis revealed no detectable VEGF mRNA in the control brains. The mRNA became evident at 1 hour after reperfusion, peaked at 3 hours, and then decreased. The length of ischemia from 1 to 3 hours made no differences in the degree and temporal profile of the subsequent induction of VEGF mRNA. (2) Western blot analysis showed no band in the control brain, but two bands with molecular weights of 38 and 45 kD, corresponding to VEGF121 and VEGF165, were induced at 1 hour of reperfusion, peaked at 3 hours of reperfusion, and then decayed. (3) Neurons in the cerebral cortex of the MCA territory expressed VEGF at 1 hour after reperfusion with a peak at 3 hours and then diminished by 1 day. Pial cells of the MCA territory also expressed immunoreactive VEGF from 1 hour of reperfusion that was sustained until 3 to 7 days after reperfusion.
Conclusions Rapid induction of VEGF gene expression after transient MCA occlusion was demonstrated at both mRNA and protein levels. Cortical neurons and pial cells were the source of VEGF production in this model, but the temporal profiles of the induction between these cells were different. The early but dissociative induction of VEGF between neuronal and pial cells suggests different roles of the protein in their cells after transient MCA occlusion.
Key Words: angiogenesis • cerebral ischemia • rats
This article has been cited by other articles:
 |
|
 |
|
  C. K. Thompson and E. A. Brenowitz Neurogenesis in an Adult Avian Song Nucleus Is Reduced by Decreasing Caspase-Mediated Apoptosis J. Neurosci., April 8, 2009; 29(14): 4586 - 4591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Obrenovitch Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia Physiol Rev, January 1, 2008; 88(1): 211 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Baranova, L. F. Miranda, P. Pichiule, I. Dragatsis, R. S. Johnson, and J. C. Chavez Neuron-Specific Inactivation of the Hypoxia Inducible Factor 1{alpha} Increases Brain Injury in a Mouse Model of Transient Focal Cerebral Ischemia J. Neurosci., June 6, 2007; 27(23): 6320 - 6332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Shimamura, G. Matchett, H. Yatsushige, J. W. Calvert, H. Ohkuma, and J. Zhang Inhibition of Integrin {alpha}v{beta}3 Ameliorates Focal Cerebral Ischemic Damage in the Rat Middle Cerebral Artery Occlusion Model Stroke, July 1, 2006; 37(7): 1902 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kimura, H. Nakase, R. Tamaki, and T. Sakaki Vascular Endothelial Growth Factor Antagonist Reduces Brain Edema Formation and Venous Infarction Stroke, June 1, 2005; 36(6): 1259 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Ardelt, L. D. McCullough, K. S. Korach, M. M. Wang, D. H. Munzenmaier, and P. D. Hurn Estradiol Regulates Angiopoietin-1 mRNA Expression Through Estrogen Receptor-{alpha} in a Rodent Experimental Stroke Model Stroke, February 1, 2005; 36(2): 337 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Osuka, Y. Watanabe, N. Usuda, A. Nakazawa, M. Tokuda, and J. Yoshida Modification of Endothelial NO Synthase Through Protein Phosphorylation After Forebrain Cerebral Ischemia/Reperfusion Stroke, November 1, 2004; 35(11): 2582 - 2586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ferrara Vascular Endothelial Growth Factor: Basic Science and Clinical Progress Endocr. Rev., August 1, 2004; 25(4): 581 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pleasure, P. Bannerman, J. Ara, M. Scarlato, and T. Itoh Prospects for Vascular Endothelial Growth Factor Neurotherapeutics Arch Neurol, May 1, 2002; 59(5): 692 - 694. [Full Text] [PDF]
|
|
|
|
 |
|
 O. O. Ogunshola, A. Antic, M. J. Donoghue, S.-Y. Fan, H. Kim, W. B. Stewart, J. A. Madri, and L. R. Ment Paracrine and Autocrine Functions of Neuronal Vascular Endothelial Growth Factor (VEGF) in the Central Nervous System J. Biol. Chem., March 22, 2002; 277(13): 11410 - 11415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-H. Lee, H. Avraham, S.-H. Lee, and S. Avraham Vascular Endothelial Growth Factor Modulates Neutrophil Transendothelial Migration via Up-regulation of Interleukin-8 in Human Brain Microvascular Endothelial Cells J. Biol. Chem., March 15, 2002; 277(12): 10445 - 10451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Q. Li, J. R. Ballinger, R. A. Nordal, Z.-F. Su, and C. S. Wong Hypoxia in Radiation-induced Blood-Spinal Cord Barrier Breakdown Cancer Res., April 1, 2001; 61(8): 3348 - 3354. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Beck, T. Acker, C. Wiessner, P. R. Allegrini, and K. H. Plate Expression of Angiopoietin-1, Angiopoietin-2, and Tie Receptors after Middle Cerebral Artery Occlusion in the Rat Am. J. Pathol., November 1, 2000; 157(5): 1473 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Jin, X. O. Mao, and D. A. Greenberg Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia PNAS, August 29, 2000; 97(18): 10242 - 10247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Maloney, D. Wang, T. Duncan, N. Voelkel, and S. Ruoss Plasma Vascular Endothelial Growth Factor in Acute Mountain Sickness Chest, July 1, 2000; 118(1): 47 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. H. Marti, M. Bernaudin, A. Bellail, H. Schoch, M. Euler, E. Petit, and W. Risau Hypoxia-Induced Vascular Endothelial Growth Factor Expression Precedes Neovascularization after Cerebral Ischemia Am. J. Pathol., March 1, 2000; 156(3): 965 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rosmorduc, D. Wendum, C. Corpechot, B. Galy, N. Sebbagh, J. Raleigh, C. Housset, and R. Poupon Hepatocellular Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Angiogenesis in Experimental Biliary Cirrhosis Am. J. Pathol., October 1, 1999; 155(4): 1065 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Marti and W. Risau Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors PNAS, December 22, 1998; 95(26): 15809 - 15814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yu, S. Tian, L. Metheny-Barlow, L.-J. Chew, A. J. Hayes, H. Pan, G.-L. Yu, and L.-Y. Li Modulation of Endothelial Cell Growth Arrest and Apoptosis by Vascular Endothelial Growth Inhibitor Circ. Res., December 7, 2001; 89(12): 1161 - 1167. [Abstract] [Full Text] [PDF]
|
|